Correlation Between Champions Oncology and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Inozyme Pharma, you can compare the effects of market volatilities on Champions Oncology and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Inozyme Pharma.
Diversification Opportunities for Champions Oncology and Inozyme Pharma
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Champions and Inozyme is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Champions Oncology i.e., Champions Oncology and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Champions Oncology and Inozyme Pharma
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.98 times more return on investment than Inozyme Pharma. However, Champions Oncology is 1.02 times less risky than Inozyme Pharma. It trades about 0.08 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.73 per unit of risk. If you would invest 398.00 in Champions Oncology on August 28, 2024 and sell it today you would earn a total of 20.00 from holding Champions Oncology or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Inozyme Pharma
Performance |
| Timeline |
| Champions Oncology |
| Inozyme Pharma |
Champions Oncology and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Inozyme Pharma
The main advantage of trading using opposite Champions Oncology and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |